mRNA Vaccines Therapeutics Market
1 Study Coverage
1.1 mRNA Vaccines & Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global mRNA Vaccines & Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global mRNA Vaccines & Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global mRNA Vaccines & Therapeutics Sales by Region
2.4.1 Global mRNA Vaccines & Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales mRNA Vaccines & Therapeutics by Region (2023-2028)
2.5 Global mRNA Vaccines & Therapeutics Revenue by Region
2.5.1 Global mRNA Vaccines & Therapeutics Revenue by Region (2017-2022)
2.5.2 Global mRNA Vaccines & Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers
3.1.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of mRNA Vaccines & Therapeutics in 2021
3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by mRNA Vaccines & Therapeutics Revenue in 2021
3.3 Global mRNA Vaccines & Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global mRNA Vaccines & Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global mRNA Vaccines & Therapeutics Sales by Type
4.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global mRNA Vaccines & Therapeutics Revenue by Type
4.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global mRNA Vaccines & Therapeutics Price by Type
4.3.1 Global mRNA Vaccines & Therapeutics Price by Type (2017-2022)
4.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global mRNA Vaccines & Therapeutics Sales by Application
5.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global mRNA Vaccines & Therapeutics Revenue by Application
5.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global mRNA Vaccines & Therapeutics Price by Application
5.3.1 Global mRNA Vaccines & Therapeutics Price by Application (2017-2022)
5.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America mRNA Vaccines & Therapeutics Market Size by Type
6.1.1 North America mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
6.1.2 North America mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
6.2 North America mRNA Vaccines & Therapeutics Market Size by Application
6.2.1 North America mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
6.2.2 North America mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
6.3 North America mRNA Vaccines & Therapeutics Market Size by Country
6.3.1 North America mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
6.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe mRNA Vaccines & Therapeutics Market Size by Type
7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
7.2 Europe mRNA Vaccines & Therapeutics Market Size by Application
7.2.1 Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
7.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
7.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
7.3.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
7.3.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Type
8.1.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Application
8.2.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Region
8.3.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America mRNA Vaccines & Therapeutics Market Size by Type
9.1.1 Latin America mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
9.2 Latin America mRNA Vaccines & Therapeutics Market Size by Application
9.2.1 Latin America mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
9.3 Latin America mRNA Vaccines & Therapeutics Market Size by Country
9.3.1 Latin America mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Type
10.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Application
10.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country
10.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Corporation Information
11.1.2 Moderna Therapeutics Overview
11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Overview
11.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CureVac mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Corporation Information
11.3.2 Translate Bio Overview
11.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Corporation Information
11.4.2 BioNTech Overview
11.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BioNTech mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Corporation Information
11.5.2 Sangamo Therapeutics Overview
11.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Corporation Information
11.6.2 Argos Therapeutics Overview
11.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Corporation Information
11.7.2 In-Cell-Art Overview
11.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Corporation Information
11.8.2 eTheRNA Overview
11.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Corporation Information
11.9.2 Ethris Overview
11.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ethris mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Corporation Information
11.10.2 Tiba Biotechnology Overview
11.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tiba Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 mRNA Vaccines & Therapeutics Industry Chain Analysis
12.2 mRNA Vaccines & Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 mRNA Vaccines & Therapeutics Production Mode & Process
12.4 mRNA Vaccines & Therapeutics Sales and Marketing
12.4.1 mRNA Vaccines & Therapeutics Sales Channels
12.4.2 mRNA Vaccines & Therapeutics Distributors
12.5 mRNA Vaccines & Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 mRNA Vaccines & Therapeutics Industry Trends
13.2 mRNA Vaccines & Therapeutics Market Drivers
13.3 mRNA Vaccines & Therapeutics Market Challenges
13.4 mRNA Vaccines & Therapeutics Market Restraints
14 Key Findings in The Global mRNA Vaccines & Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Infectious Disease Vaccines
Table 3. Major Manufacturers of Cancer Vaccines
Table 4. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global mRNA Vaccines & Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global mRNA Vaccines & Therapeutics Sales by Region (2017-2022) & (M Doses)
Table 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2022)
Table 8. Global mRNA Vaccines & Therapeutics Sales by Region (2023-2028) & (M Doses)
Table 9. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2023-2028)
Table 10. Global mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2017-2022)
Table 12. Global mRNA Vaccines & Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2023-2028)
Table 14. Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturers (2017-2022)
Table 16. Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2017-2022)
Table 18. mRNA Vaccines & Therapeutics Price by Manufacturers (2017-2022) &(USD/Doses)
Table 19. Global mRNA Vaccines & Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines & Therapeutics as of 2021)
Table 21. mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers mRNA Vaccines & Therapeutics Product Offered
Table 23. Date of Manufacturers Enter into mRNA Vaccines & Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 26. Global mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 27. Global mRNA Vaccines & Therapeutics Sales Share by Type (2017-2022)
Table 28. Global mRNA Vaccines & Therapeutics Sales Share by Type (2023-2028)
Table 29. Global mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global mRNA Vaccines & Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2017-2022)
Table 32. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2023-2028)
Table 33. mRNA Vaccines & Therapeutics Price by Type (2017-2022) & (USD/Doses)
Table 34. Global mRNA Vaccines & Therapeutics Price Forecast by Type (2023-2028) & (USD/Doses)
Table 35. Global mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 36. Global mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 37. Global mRNA Vaccines & Therapeutics Sales Share by Application (2017-2022)
Table 38. Global mRNA Vaccines & Therapeutics Sales Share by Application (2023-2028)
Table 39. Global mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global mRNA Vaccines & Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2017-2022)
Table 42. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2023-2028)
Table 43. mRNA Vaccines & Therapeutics Price by Application (2017-2022) & (USD/Doses)
Table 44. Global mRNA Vaccines & Therapeutics Price Forecast by Application (2023-2028) & (USD/Doses)
Table 45. North America mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 46. North America mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 47. North America mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America mRNA Vaccines & Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 50. North America mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 51. North America mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America mRNA Vaccines & Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
Table 54. North America mRNA Vaccines & Therapeutics Sales by Country (2023-2028) & (M Doses)
Table 55. North America mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America mRNA Vaccines & Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 58. Europe mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 59. Europe mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe mRNA Vaccines & Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 62. Europe mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 63. Europe mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe mRNA Vaccines & Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
Table 66. Europe mRNA Vaccines & Therapeutics Sales by Country (2023-2028) & (M Doses)
Table 67. Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe mRNA Vaccines & Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America mRNA Vaccines & Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America mRNA Vaccines & Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America mRNA Vaccines & Therapeutics Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 105. Moderna Therapeutics Corporation Information
Table 106. Moderna Therapeutics Description and Major Businesses
Table 107. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 108. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Moderna Therapeutics Recent Developments
Table 110. CureVac Corporation Information
Table 111. CureVac Description and Major Businesses
Table 112. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 113. CureVac mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. CureVac Recent Developments
Table 115. Translate Bio Corporation Information
Table 116. Translate Bio Description and Major Businesses
Table 117. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 118. Translate Bio mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Translate Bio Recent Developments
Table 120. BioNTech Corporation Information
Table 121. BioNTech Description and Major Businesses
Table 122. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 123. BioNTech mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. BioNTech Recent Developments
Table 125. Sangamo Therapeutics Corporation Information
Table 126. Sangamo Therapeutics Description and Major Businesses
Table 127. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 128. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Sangamo Therapeutics Recent Developments
Table 130. Argos Therapeutics Corporation Information
Table 131. Argos Therapeutics Description and Major Businesses
Table 132. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 133. Argos Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Argos Therapeutics Recent Developments
Table 135. In-Cell-Art Corporation Information
Table 136. In-Cell-Art Description and Major Businesses
Table 137. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 138. In-Cell-Art mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. In-Cell-Art Recent Developments
Table 140. eTheRNA Corporation Information
Table 141. eTheRNA Description and Major Businesses
Table 142. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 143. eTheRNA mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. eTheRNA Recent Developments
Table 145. Ethris Corporation Information
Table 146. Ethris Description and Major Businesses
Table 147. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 148. Ethris mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Ethris Recent Developments
Table 150. Tiba Biotechnology Corporation Information
Table 151. Tiba Biotechnology Description and Major Businesses
Table 152. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 153. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Tiba Biotechnology Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. mRNA Vaccines & Therapeutics Distributors List
Table 158. mRNA Vaccines & Therapeutics Customers List
Table 159. mRNA Vaccines & Therapeutics Market Trends
Table 160. mRNA Vaccines & Therapeutics Market Drivers
Table 161. mRNA Vaccines & Therapeutics Market Challenges
Table 162. mRNA Vaccines & Therapeutics Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Product Picture
Figure 3. Global mRNA Vaccines & Therapeutics Market Share by Type in 2021 & 2028
Figure 3. Infectious Disease Vaccines Product Picture
Figure 4. Cancer Vaccines Product Picture
Figure 5. Global mRNA Vaccines & Therapeutics Market Share by Application in 2021 & 2028
Figure 6. Infectious Disease
Figure 7. Cancer
Figure 8. mRNA Vaccines & Therapeutics Report Years Considered
Figure 9. Global mRNA Vaccines & Therapeutics Sales 2017-2028 (M Doses)
Figure 10. Global mRNA Vaccines & Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global mRNA Vaccines & Therapeutics Revenue 2017-2028 (US$ Million)
Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2022)
Figure 14. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2023-2028)
Figure 15. North America mRNA Vaccines & Therapeutics Sales YoY (2017-2028) & (M Doses)
Figure 16. North America mRNA Vaccines & Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe mRNA Vaccines & Therapeutics Sales YoY (2017-2028) & (M Doses)
Figure 18. Europe mRNA Vaccines & Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific mRNA Vaccines & Therapeutics Sales YoY (2017-2028) & (M Doses)
Figure 20. Asia-Pacific mRNA Vaccines & Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America mRNA Vaccines & Therapeutics Sales YoY (2017-2028) & (M Doses)
Figure 22. Latin America mRNA Vaccines & Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa mRNA Vaccines & Therapeutics Sales YoY (2017-2028) & (M Doses)
Figure 24. Middle East & Africa mRNA Vaccines & Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The mRNA Vaccines & Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of mRNA Vaccines & Therapeutics in the World: Market Share by mRNA Vaccines & Therapeutics Revenue in 2021
Figure 27. Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 29. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
Figure 30. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 31. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
Figure 32. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 33. North America mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
Figure 34. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 35. North America mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
Figure 36. North America mRNA Vaccines & Therapeutics Sales Share by Country (2017-2028)
Figure 37. North America mRNA Vaccines & Therapeutics Revenue Share by Country (2017-2028)
Figure 38. United States mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 39. Canada mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 40. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 41. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
Figure 42. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 43. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
Figure 44. Europe mRNA Vaccines & Therapeutics Sales Share by Country (2017-2028)
Figure 45. Europe mRNA Vaccines & Therapeutics Revenue Share by Country (2017-2028)
Figure 46. Germany mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 47. France mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 49. Italy mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 50. Russia mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific mRNA Vaccines & Therapeutics Sales Share by Region (2017-2028)
Figure 56. Asia Pacific mRNA Vaccines & Therapeutics Revenue Share by Region (2017-2028)
Figure 57. China mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 58. Japan mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 60. India mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 61. Australia mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 67. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
Figure 68. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 69. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
Figure 70. Latin America mRNA Vaccines & Therapeutics Sales Share by Country (2017-2028)
Figure 71. Latin America mRNA Vaccines & Therapeutics Revenue Share by Country (2017-2028)
Figure 72. Mexico mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa mRNA Vaccines & Therapeutics Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Share by Country (2017-2028)
Figure 81. Turkey mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 83. UAE mRNA Vaccines & Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 84. mRNA Vaccines & Therapeutics Value Chain
Figure 85. mRNA Vaccines & Therapeutics Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Industry Market Size
